Company news
Obsidian Therapeutics, Inc. news
Latest news releases, newest first.
Obsidian Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates
November 12, 2026
Obsidian Therapeutics to Present Updated Amsoki-cel Efficacy and Pooled Safety Data in Advanced Melanoma at SITC 2026 Annual Meeting
November 6, 2026
Obsidian Therapeutics to Present Updated Amsoki-cel (OBX-115) Phase 1/2 Data in Advanced Melanoma at SITC 2026 Annual Meeting
October 2, 2026
Obsidian Therapeutics Announces First Patient Enrolled in the Registration-enabling Cohort of Phase 1/2 Agni-01 Study Evaluating Amsoki-cel (OBX-115) in Advanced Melanoma
August 5, 2026
Decks
- Investor Presentation (August 2026)
Investor deck · 27 slides · August 2026